ENSC
Price
$2.38
Change
+$0.04 (+1.71%)
Updated
Jun 6 closing price
Capitalization
5.51M
MLLCF
Price
$4.22
Change
-$0.00 (-0.00%)
Updated
Apr 25 closing price
Capitalization
134.75M
Interact to see
Advertisement

ENSC vs MLLCF

Header iconENSC vs MLLCF Comparison
Open Charts ENSC vs MLLCFBanner chart's image
Ensysce Biosciences
Price$2.38
Change+$0.04 (+1.71%)
Volume$80.84K
Capitalization5.51M
Molecular Partners AG
Price$4.22
Change-$0.00 (-0.00%)
Volume$1.33K
Capitalization134.75M
ENSC vs MLLCF Comparison Chart
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. MLLCF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Buy and MLLCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ENSC: $2.38 vs. MLLCF: $4.22)
Brand notoriety: ENSC and MLLCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 3% vs. MLLCF: 143%
Market capitalization -- ENSC: $5.51M vs. MLLCF: $134.75M
ENSC [@Biotechnology] is valued at $5.51M. MLLCF’s [@Biotechnology] market capitalization is $134.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileMLLCF’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • MLLCF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENSC is a better buy in the long-term than MLLCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 5 TA indicator(s) are bullish.

  • ENSC’s TA Score: 5 bullish, 1 bearish.

Price Growth

ENSC (@Biotechnology) experienced а +7.21% price change this week, while MLLCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ENSC is expected to report earnings on Mar 10, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLLCF($135M) has a higher market cap than ENSC($5.51M). MLLCF YTD gains are higher at: 2.676 vs. ENSC (-70.762). ENSC has higher annual earnings (EBITDA): -6.7M vs. MLLCF (-51.65M). MLLCF has more cash in the bank: 149M vs. ENSC (3.5M). ENSC has less debt than MLLCF: ENSC (302K) vs MLLCF (2.44M). MLLCF has higher revenues than ENSC: MLLCF (4.97M) vs ENSC (0).
ENSCMLLCFENSC / MLLCF
Capitalization5.51M135M4%
EBITDA-6.7M-51.65M13%
Gain YTD-70.7622.676-2,644%
P/E Ratio0.02N/A-
Revenue04.97M-
Total Cash3.5M149M2%
Total Debt302K2.44M12%
FUNDAMENTALS RATINGS
ENSC vs MLLCF: Fundamental Ratings
ENSC
MLLCF
OUTLOOK RATING
1..100
2947
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
6558
P/E GROWTH RATING
1..100
6386
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (28) in the null industry is in the same range as MLLCF (37). This means that ENSC’s stock grew similarly to MLLCF’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as MLLCF (100). This means that ENSC’s stock grew similarly to MLLCF’s over the last 12 months.

MLLCF's SMR Rating (94) in the null industry is in the same range as ENSC (99). This means that MLLCF’s stock grew similarly to ENSC’s over the last 12 months.

MLLCF's Price Growth Rating (58) in the null industry is in the same range as ENSC (65). This means that MLLCF’s stock grew similarly to ENSC’s over the last 12 months.

ENSC's P/E Growth Rating (63) in the null industry is in the same range as MLLCF (86). This means that ENSC’s stock grew similarly to MLLCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNO38.620.76
+2.01%
CNO Financial Group
TLSA1.430.02
+1.42%
Tiziana Life Sciences Ltd
BG74.550.70
+0.95%
Bunge Global SA
VREX8.420.05
+0.60%
Varex Imaging Corp
HSCS3.58-0.01
-0.28%
HeartSciences Inc

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
+1.71%
MLLCF - ENSC
37%
Loosely correlated
N/A
HNSBF - ENSC
33%
Loosely correlated
N/A
SYRE - ENSC
31%
Poorly correlated
+2.11%
NEUP - ENSC
31%
Poorly correlated
-3.92%
YMAB - ENSC
30%
Poorly correlated
+3.33%
More

MLLCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLLCF has been loosely correlated with ENSC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MLLCF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLLCF
1D Price
Change %
MLLCF100%
N/A
ENSC - MLLCF
37%
Loosely correlated
+1.71%
CYYNF - MLLCF
31%
Poorly correlated
N/A
HNSBF - MLLCF
27%
Poorly correlated
N/A
URGN - MLLCF
26%
Poorly correlated
+43.39%
GNPX - MLLCF
24%
Poorly correlated
+5.43%
More